✦ LIBER ✦

The action of the drug prenylamine (Segontin) on exploratory activity in strains of rats selectively bred for differences in emotionality

✍ Scribed by Keir Gregory

Publisher: Springer
Year: 1968
Tongue: English
Weight: 319 KB
Volume: 13
Category: Article
ISSN: 0033-3158
DOI: 10.1007/bf00401616

No coin nor oath required. For personal study only.

✦ Synopsis

The action of 20 mg/kg, i.p. of the drug prenylamine (Segontin) upon two forms of exploratory activity was examined in strains of rats selectively bred for differences in emotionality. The drug significantly depressed ambulation in an Open Field arena compared to placebo and although not apparently related to a strain specific action of the drug, this depression was greater in the more emotional Reactive strain. On the rearing frequency the depressive effect was not statistically significant and, further, no strain differences were revealed in this situation.

📜 SIMILAR VOLUMES

The action of the drug prenylamine (Sego

The action of the drug prenylamine (Segontin) on exploratory activity and aversive learning in a selected strain of rats

✍ Keir Gregory 📂 Article 📅 1968 🏛 Springer 🌐 English ⚖ 379 KB

Sixteen rats of both sexes of a strain selectively bred for high performance levels in an aversive learning task, were examined for differences in rearing frequency and escape/avoidance performance under various doses of the drugs reserpine and prenylamine. At the highest dosages employed 4.0 mg/kg

An examination of the effects of stimula

An examination of the effects of stimulant and depressant drugs on escape/avoidance conditioning in strains of rats selectively bred for emotionality/non-emotionality

✍ B. D. Gupta; H. C. Holland 📂 Article 📅 1969 🏛 Springer 🌐 English ⚖ 617 KB

The effects of different doses of methyl

The effects of different doses of methylpentynol on escape/avoidance conditioning in two strains of rats selectively bred for high and low “emotionality”

✍ H. C. Holland; B. D. Gupta 📂 Article 📅 1966 🏛 Springer 🌐 English ⚖ 362 KB

Any adequate evaluation of the behavioral effects of a pharmacological compound, particularly where it is assumed to act upon the nervous system, must include consideration of at least three individual factors: (a) the designated activity whereby the effect is to be measured; (b) the dosage function